Leadership Overview
ECRI has 5 executives leading key functions including clinical strategy, organizational culture, executive management, historical vision, and legal operations.
Committed to advancing healthcare safety and quality, ECRI drives evidence-based practices and independent medical device evaluations to improve patient outcomes across global healthcare settings.
Committed to advancing healthcare safety and quality, ECRI drives evidence-based practices and independent medical device evaluations to improve patient outcomes across global healthcare settings.
Leadership Roles at ECRI
David Marx - President, The Just Culture Company
David Marx, the President, The Just Culture Company at ECRI, architects organizational frameworks that prioritize safety and accountability within healthcare systems. Overseeing the implementation of Just Culture principles, the President, The Just Culture Company drives cultural transformation to reduce medical errors and improve reporting transparency. David Marx works alongside clinical leaders to design systems that support staff while maintaining high standards of patient safety. This role involves developing educational programs that shift institutional focus from blame to systemic improvement. By analyzing human factors in clinical settings, the President, The Just Culture Company provides the necessary tools for healthcare organizations to manage risk effectively. Through strategic partnerships, the President, The Just Culture Company expands the reach of safety methodologies across diverse medical environments. David Marx ensures that the principles of fairness and learning remain central to the broader mission of enhancing healthcare quality and operational efficiency globally.
Xiaojuan Wang - President
Xiaojuan Wang, the President at ECRI, directs the overall strategic vision and operational execution of the organization. Overseeing the expansion of independent research and testing capabilities, the President ensures that the nonprofit maintains its reputation for integrity and evidence-based excellence. Xiaojuan Wang manages the integration of affiliate organizations, such as the Institute for Safe Medication Practices, to broaden the scope of patient safety services. This leadership role involves coordinating with the Board and executive team to align resources with the mission of advancing healthcare quality. By fostering innovation in technology decision support, the President drives the development of tools that assist healthcare leaders in making informed procurement and safety decisions. Xiaojuan Wang oversees the global footprint of the organization, ensuring that testing laboratories in North America and the Asia Pacific region operate with consistent rigor. Through disciplined management, the President secures the long-term sustainability of the organization's vital public health contributions.
Joel Nobel - Founder and President Emeritus
Joel Nobel, the Founder and President Emeritus at ECRI, provides foundational guidance and historical perspective to the current leadership team. Overseeing the preservation of the organization's core values, the Founder and President Emeritus ensures that the commitment to independence and rigorous research remains the cornerstone of all operations. Joel Nobel advises on long-term strategic initiatives, drawing upon decades of experience in medical technology evaluation and patient safety advocacy. This role involves mentoring current executives to maintain the high standards established during the organization's inception. By championing the importance of objective, evidence-based practices, the Founder and President Emeritus reinforces the trust placed in the organization by government agencies and healthcare providers. Joel Nobel supports the ongoing mission by advocating for the necessity of independent device testing in an increasingly complex medical landscape. Through this enduring influence, the Founder and President Emeritus helps shape the future trajectory of healthcare safety and quality improvement efforts.
Dheerendra Kommala - Chief Medical Officer
Dheerendra Kommala, the Chief Medical Officer at ECRI, directs clinical strategy and patient safety initiatives across all healthcare settings. Overseeing evidence-based practice research, the Chief Medical Officer ensures that medical device evaluations meet rigorous safety standards. Dheerendra Kommala collaborates with government agencies to implement technology decision support systems that reduce clinical risks. By analyzing complex data sets, the Chief Medical Officer identifies emerging hazards in medical technology, providing actionable insights to hospital systems. This leadership role involves guiding clinical teams toward improved quality metrics and cost-effective care delivery. Through the integration of clinical expertise and research, the Chief Medical Officer maintains the integrity of independent evaluations. Dheerendra Kommala supports the organization's mission by bridging the gap between technical testing and bedside safety, ultimately fostering a culture of continuous improvement in patient care environments throughout North America and the Asia Pacific region.
Ronni Solomon - Executive Vice President & General Counsel
Ronni Solomon, the Executive Vice President & General Counsel at ECRI, directs all legal affairs, compliance, and corporate governance initiatives. Overseeing the strict conflict-of-interest policies, the Executive Vice President & General Counsel ensures that the organization maintains its status as an independent, nonprofit entity. Ronni Solomon manages complex contractual relationships with government agencies and healthcare partners, providing the legal framework necessary for global operations. This leadership role involves navigating regulatory requirements for federally certified Patient Safety Organizations and Evidence-based Practice Centers. By mitigating legal risks, the Executive Vice President & General Counsel protects the integrity of the research and testing processes. Ronni Solomon collaborates with the executive team to ensure that all strategic initiatives align with the organization's mission and legal obligations. Through meticulous oversight of corporate policy, the Executive Vice President & General Counsel supports the stability and credibility of the organization's work in advancing healthcare safety and cost-effectiveness across all settings.
Explore Leadership Teams in Business Services
The US National Center for Atmospheric Research is a US federally funded research and development center managed by the nonprofit University Corporation for Atmospheric Research and funded by the National Science Foundation.
Company Leadership
GM
PAREXEL International Corporation, a biopharmaceutical outsourcing services company, provides clinical research and logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting Services (PC), and PAREXEL Informatics (PI). The CRS segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, data management, and biostatistical analysis, epidemiology and health economics/outcomes research, clinical supply and drug logistics, pharmacovigilance, commercialization, and clinical pharmacology, as well as related medical affairs, patient recruitment, and investigator site services. The PC segment provides technical expertise and advice in various areas, such as drug development, regulatory affairs, product pricing and reimbursement, commercialization, and strategic compliance; and market and product development, and targeted communications services to support product launch, as well as offers solutions to address client issues associated with product development, registration, and commercialization. The PI segment provides information technology solutions comprising ClinPhone randomization and trial supply management solutions, medical imaging services, IMPACT clinical trial management systems, LIQUENT InSight regulatory information management software and professional services, DataLabs electronic data capture systems, Web-based portals, systems integration services, electronic patient reported outcomes, and patient diary applications, as well as centralized assessment services for patient technology solutions. PAREXEL International Corporation was founded in 1983 and is headquartered in Waltham,...
Company Leadership FB
GS
A global leader in applied safety science, UL Solutions transforms safety, security and sustainability challenges into opportunities for customers. We deliver testing, inspection and certification services, plus software and advisory offerings that support our customers product innovation and business growth.
Company Leadership
CZ
CS
The GLI Group of Companies form an inter-disciplinary approach to Compliance, Independent Verification & Validation (IV&V) and Quality Assurance (QA) testing solutions to our clients while meeting their cyber-security and other IT professional services needs. The GLI Group is made up of several entities as described below.
Company Leadership EH
TR
IT
Frequently Asked Questions Regarding ECRI Top Executives and Leadership Team
Unlock more people and company data
